India's Serum Institute says to meet local demand for AstraZeneca vaccine for next two months, before exporting

Chief Executive Adar Poonawalla said in an interview after the shot was approved for emergency use in the world's second-most populous country, that exports might be possible after supplying the Indian government with an initial 100 million doses.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3pDzbSq
via IFTTT